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Background: Stem cell therapy is expected to offer new alternatives to the traditional therapies of rotator cuff tendon tears. In
particular, resident, tissue-specific, adult stem cells seem to have a higher regenerative potential for the tissue where they reside.
Hypothesis: Rotator cuff tendon and long head of the biceps tendon possess a resident stem cell population that, when properly
stimulated, may be induced to proliferate, thus being potentially usable for tendon regeneration.
Study Design: Controlled laboratory study.
Methods: Human tendon samples from the supraspinatus and the long head of the biceps were collected during rotator cuff ten-
don surgeries from 26 patients, washed with phosphate-buffered saline, cut into small pieces, and digested with collagenase type
I and dispase. After centrifugation, cell pellets were resuspended in appropriate culture medium and plated. Adherent cells were
cultured, phenotypically characterized, and then compared with human bone marrow stromal cells (BMSCs), as an example of
adult stem cells, and human dermal fibroblasts, as normal proliferating cells with no stem cell properties.
Results: Two new adult stem cell populations from the supraspinatus and long head of the biceps tendons were isolated, char-
acterized, and cultured in vitro. Cells showed adult stem cell characteristics (ie, they were self-renewing in vitro, clonogenic, and
multipotent), as they could be induced to differentiate into different cell types—namely, osteoblasts, adipocytes, and skeletal
muscle cells.
Conclusion: This work demonstrated that human rotator cuff tendon stem cells and human long head of the biceps tendon stem
cells can be isolated and possess a high regenerative potential, which is comparable with that of BMSCs. Moreover, comparative
analysis of the sphingolipid pattern of isolated cells with that of BMSCs and fibroblasts revealed the possibility of using this class
of lipids as new possible markers of the cell differentiation status.
Clinical Relevance: Rotator cuff and long head of the biceps tendons contain a stem cell population that can proliferate in vitro
and could constitute an easily accessible stem cell source to develop novel therapies for tendon regeneration.
Keywords: stem cells; rotator cuff tendon; sphingolipids; regenerative medicine
Rotator cuff tendons are often prone to lesions and full-
thickness tears, as 30% to 50% of the population older
than 50 years has partial- or full-thickness rotator cuff
tears.9,27 Although surgical procedures have evolved and
improved over the past decades, reruptures are still very
common,26 and the overall failure rates of surgical repair
range from 30% to 94%, which is far from being accept-
able.13 Several new ‘‘biological’’ approaches have been
developed to overcome this issue, including the use of
growth factors,25 bone morphogenetic proteins,2 and,
more recently, stem cells.6 Research on stem cells for tissue
engineering has bloomed over the past decade, although
a therapeutic application in tendon repair has yet to be
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fully developed.23 Among adult stem cells, bone marrow
stromal cells (BMSCs) are by far the most studied. How-
ever, tendon-derived stem cells (TDSCs) have also been
found in several animal species, including humans.3,19
These results have been recently extensively reviewed,
underlying the potential of tendon stem cells in tendon
lesions and in tissue engineering applications.19 In fact, it
has been demonstrated that tendons have a resident pro-
genitor cell population that possesses several universal
characteristics proper of adult stem cells, including clonoge-
nicity, self-renewal, and multipotent differentiation capac-
ity.3 Although tenocyte-like cells have been recently
isolated and cultured in vitro,24 the isolation of a cell popu-
lation with stem cell characteristics from the human rotator
cuff has yet to be reported. Moreover, although BMSCs have
been shown to be able to differentiate into several mesen-
chymal tissues, including tendons,12 the possibility of isolat-
ing tendon-specific stem cells is desirable, as progenitor cells
are more prone to differentiate into those cell types that
belong to the tissue in which they reside32: they form stem
cell reservoirs, the ‘‘niches’’10 that can regulate the physio-
logical turnover of differentiated cells, also in organs such
as the brain and the heart, which have been recently proven
to undergo some regeneration during aging.5,33 Along this
line, a very recent study reported an in-depth comparison
of the phenotype and the regenerative potential of rat
TDSCs and BMSCs.31 Interestingly, the authors found
that TDSCs possess a higher proliferative rate and multili-
neage differentiation potential than BMSCs, therefore con-
cluding that TDSCs are a very promising stem cell source
for musculoskeletal tissue engineering.
The aim of this study is the isolation and characteriza-
tion of new adult stem cell populations from the supraspi-
natus (SS), which is part of the rotator cuff, and from the
long head of the biceps (LHB) tendons (Figure 1, A-C). To
confirm our hypothesis, it has been necessary that these
SS and LHB cells could be cultured and expanded and
that they showed adult stem cell characteristics (ie, they
are self-renewing in vitro, clonogenic, and multipotent),
as they could be induced to differentiate in vitro into dif-
ferent cell types, including osteoblasts, adipocytes, and
skeletal muscle cells. These new cell populations should
be phenotypically characterized and compared with
BMSCs and human dermal fibroblasts (DFs). Moreover,
as sphingolipids are emerging key regulatory molecules
of stem cell proliferation and differentiation,15 the sphin-
golipid pattern of all cells should be determined. Finally,
the differentiation potential of these new tendon stem
cells should be compared with those of bone marrow
stem cells and dermal fibroblasts. In fact, as a variety of
stem cell sources have become available, it seems desir-
able and useful to have comparative data to test their dif-
ferentiation potential toward different cell types, thus
clarifying what works best for the regeneration of a spe-
cific tissue.
Therefore, the working hypothesis of this study is that
the rotator cuff tendon does possess a resident stem cell
population that, when properly stimulated, may be
induced to proliferate, thus being potentially usable for
tendon regeneration.
MATERIALS AND METHODS
Cell Isolation and Culture
Human tendon samples were collected during arthroscopic
rotator cuff repairs as described below. The protocol study
was approved by the Hospital Ethical Committee (authoriza-
tion number 2642; September 19, 2011). Patients were
recruited among those electing to undergo an arthroscopic
cuff repair. Patients with a rotator cuff tear diagnosed by pre-
operative magnetic resonance imaging and verified by intra-
operative evaluation and who gave written informed consent
were included in this study. Both chronic and acute tears
were included. The exclusion criterion was the presence of
unequivocally diagnosed concomitant disorders of the shoul-
der, including glenohumeral arthritis, fracture, osteonecro-
sis, instability, or infection. None of the patients had
undergone prior surgery on the affected shoulder. Specimens
were obtained from 26 consecutive patients during arthro-
scopic rotator cuff repairs. There were 10 male and 16 female
patients with a mean 6 SD age of 60 6 7 years. The mean
duration of symptoms was 26 months (range, 6-96 months).
Intra-articular findings of the rotator cuff were classified
according to Snyder.29 There were 18 complete tears (degree:
C1-C4), 4 bursal surface lesions (degree: B2-B4), and 4 artic-
ular surface lesions (degree: A2-A3). Partial articular and
bursal surface lesions were converted to full-thickness tears.
Samples were collected from SS and LHB tendons in 20 and
6 patients, respectively (Figure 1, A-C). None of the 2 differ-
ent tendons were collected from the same patient. Arthro-
scopic rotator cuff repair was performed by the single-row
technique with 1 to 3 suture anchors. Before the repair, a sin-
gle specimen was taken from the residual tendon. The
arthroscope was inserted in the glenohumeral joint, and
once the cuff tear was identified, the frayed edge of the
tear was debrided until normal tendon fibers were identified.
A margin of 4 to 8 mmwas removed from the edge of the torn
supraspinatus tendon before surgical repair by use of an
arthroscopic basket punch. The LHB tissue specimens were
harvested from the midportion of the intra-articular part of
the LHB by arthroscopic tenotomy of the damaged tendon.
Samples from SS and LHB tendons (4-8 mm wide) (Figure
1D) were collected from 26 patients, kept in HypoThermosol
(BioLife Solutions, Bothell, Washington) at 4C, and pro-
cessed separately within 24 hours, according to the procedure
described below.
Samples were washed with phosphate-buffered saline
(PBS), cut into small pieces, and digested for 90 minutes
with collagenase type I (3 mg/mL; Worthington, Lakewood,
New Jersey) and dispase (4 mg/mL; Gibco, Life Technolo-
gies, Carlsbad, California) in PBS (Euroclone, Pero, Italy)
at 37C. After centrifugation, cell pellets were resuspended
in the following culture medium: a-MEM (Sigma-Aldrich,
St Louis, Missouri) supplemented with 2 mM glutamine,
100 IU/mL penicillin, 100 mg/mL streptomycin, and 20%
fetal bovine serum (FBS), embryonic stem cell tested and
European Union approved (PAA Laboratories, Pasching,
Austria). Cells were then filtered with a cell strainer
(70 mM; BD Falcon, San Jose, California) and plated in
150-cm2 dishes. Adherent cells were cultured at 37C in
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Figure 1. Isolation and characterization of tendon-derived stem cells (TDSCs): comparison with dermal fibroblasts (DFs) and
bone marrow stromal cells (BMSCs). (A) Cadaveric picture of shoulder joint with supraspinatus (SS) and long head of the biceps
(LHB) tendons indicated by black arrows. (B, C) Representative arthroscopic pictures of the site of fragment collection. (D) Picture
of a tendon fragment collected before trituration and processing. (E) Schematic representation of the protocol used to isolate ten-
don stem cells. (F) Comparative features of TDSCs (SS and LHB) to human DFs and human bone marrow stromal cells (BMSCs):
phase-contrast microphotographs (310 magnification). (G, H) Clonogenic assays and colony-forming efficiency. (I) Cell growth
curves and (J) cell cycle analysis of DFs, BMSCs, and SS and LHB cells (G2/M, S, G0/G1). All experiments were performed in
triplicates. Error bars show mean 6 SD of 3 different experiments (6 in the case of the clonogenic assay); significance according
to 2-way ANOVA: ***P\ .001 compared with DF.
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a humidified atmosphere with 5% CO2. Cells were isolated
from all 26 patients. The number of isolated cells from dif-
ferent patients was generally similar and proportional to
the tendon fragment size. In all cases, cells could be
expanded to at least passage 6 before showing clear signs
of senescence. All experiments were carried out at
cell passage 3 from seeding. Cells were seeded at
4000 cells/cm2 density and were passaged when they
reached 80% confluence, generally after 48 hours from seed-
ing. Human bone marrow stem cells, obtained from healthy
donors, were cultured in low-glucose Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 4 mM gluta-
mine, 100 IU/mL penicillin, 100 mg/mL streptomycin (all
reagents purchased from Sigma-Aldrich), and 10% (v/v)
defined FBS (HyClone; Thermo-Fisher Scientific, Waltham,
Massachusetts). Human DFs (from ATCC; LGC Standards
Srl, Sesto San Giovanni, Italy) and the mouse myogenic
cell line C2C12 (ATCC; LGC Standards Srl) were main-
tained in high-glucose DMEM supplemented with 4 mM
glutamine, 100 IU/mL penicillin, 100 mg/mL streptomycin,
and 10% (v/v) FBS (Sigma-Aldrich).
Clonogenic Assay
This assay tests the capability of stem cells to form clones
starting from single-cell cultures. To this purpose, cells
need to be seeded at a very high dilution. Suspensions of
2000 cells (for counts, see below) were plated in 60-mm
dishes and cultured for 9 days. Cell colonies were stained
with crystal violet (Sigma-Aldrich) for 10 minutes as previ-
ously described.4 Results shown are the average of 6 experi-
ments for each cell type. The DFs and BMSCs were used as
controls. We used all 6 different samples of the LHB, as
we collected them from 6 patients (3 men and 3 women;
average age, 57 years; range, 50-67 years). Therefore, we
decided to pick 6 matching samples out of the 20 supraspi-
natus tendons (3 men and 3 women; average age, 58 years;
range, 53-67 years) and tested them separately.
Cell Structure and Growth Curve
For growth curve only, cells were plated at the concentration
of 3 3 103 cells/cm2. Cell structure was examined daily with
a phase-contrast microscope (Axiovert 40 CFL; Zeiss, Arese,
Italy). Cells were counted at days 1, 2, 3, and 4 with a Count-
ess Cell Counter (Invitrogen; Life Technologies), and cell via-
bility was determined by trypan blue dye exclusion assay.
Flow Cytometry
Isolated cells were characterized by flow cytometry for the
expression of key stem cell markers and to test the level
of contamination with other cell types. Cell cycle analysis
allowed us to test the proliferation status of all studied cells.
Flow cytometry analysis was performed on 23 105 cells.
Briefly, cells were stained with a 3-step procedure: (1) incu-
bation for 30 minutes at 4C with 50% FBS (M-Medical,
Cornaredo, Italy) in PBS to block the Fc receptor, (2) incu-
bation with conjugated mouse antihuman antibodies at the
optimal concentration (1:20 dilution) in PBS for
10 minutes at 4C, and (3) 2 washes with PBS at 4C. Sam-
ples were analyzed with a Navios cytofluorimeter (Beck-
man Coulter, Brea, California), and data were processed
with Kaluza software (Beckman Coulter). Cell characteriza-
tion was performed using the following antibodies: aCD9
FITC, aCD73 FITC, aHLA-DR FITC, aCD13 PE, aCD29
PE, aCD45 PE, aCD71 PE, aCD90 PE, aCD105 PE, aPE,
a-4 PE, and aCD34 PerCP-eFluor710 (all from eBioscience,
San Diego, California); aLineage Cocktail FITC, aCD18 PE,
aCD146 PE, and aStro-1 Alexa Fluor 647 (all from BioLe-
gend, San Diego, California); and aCD117 PE (Miltenyi Bio-
tech, Bergisch Gladbach, Germany). Cell cycle analysis was
performed on samples containing 106 cells. Briefly, cells
were fixed in 70% ethanol and kept at 4C before staining.
Cells were then incubated with 10 mg/mL propidium iodide
(Propidium Iodide Solution; BioLegend) and diluted in 1 mL
PBS, 0.5% Tween 20 (Carlo Erba, Arese, Italy), and 1%
bovine serum albumin (Sigma-Aldrich), adding 20 mg/mL
RNAse A (Sigma-Aldrich). Staining was performed over-
night at 4C. Samples were analyzed with a Navios cyto-
fluorimeter (Beckman Coulter), and data were processed
with Kaluza software.
Real-Time Reverse Transcription
Polymerase Chain Reaction
Expression of key markers involved in extracellular matrix
remodeling and homeostasis was tested by quantitative
polymerase chain reaction (qPCR). Total RNA was isolated
by a modification of the acid guanidinium thiocyanate-
phenol-chloroform method (Tri-Reagent; Sigma-Aldrich).
Total RNA (1 mg) was reverse-transcribed in a 20-mL final
volume of reaction mix (BioRad, Hercules, California). The
mRNA levels of collagen type I and type III (COL-I, COL-
III), matrix metalloproteinase 1 and 2 (MMP-1, MMP-2),
transforming growth factor–b1 (TGF-b1), N-cadherin
(N-cad), and connexin 43 (Cx43) were assessed. Glycer-
aldehyde-3-phosphate dehydrogenase (GAPDH) was used
as endogenous control to normalize the differences in the
amount of total RNA in each sample.
The primer sequences, designed with Beacon Designer
6.0 Software (BioRad), were the following:
GAPDH: FW-CCCTTCATTGACCTCAACTACATG,
REV-TGGGATTTCCATTGATGACAAGC
COL-I: FW-CGACCTGGTGAGAGAGGAGTTG,
REV-AATCCATCCAGACCATTGTGTCC
COL-III: FW-TGTCAAGTCTGGAGTAGCAGTAGG,
REV-GGAACCAGGATGACCAGATGTACC
MMP-1: FW-CGGATACCCCAAGGACATCTACAG,
REV-GCCAATTCCAGGAAAGTCATGTGC
MMP-2: FW-GCAGTGCAATACCTGAACACCTTC,
REV-TCTGGTCAAGATCACCTGTCTGG
TGF-b1: FW-GTGCGGCAGTGGTTGAGC,
REV-GGTAGTGAACCCGTTGATGTCC
N-cad: FW-CTCTCGCCTATGTCTCCTCCTG,
REV-TTTGCTCACTTGCTTGCTTGTTG,
REV-TTGGAGCCTGAGACACGATTCTG
Cx43: FW-CTCTCGCCTATGTCTCCTCCTG,
REV-TTTGCTCACTTGCTTGCTTGTTG
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Amplification reactions were conducted in a 96-well
plate in a final volume of 20 mL per well containing
10 mL of 13 SYBR Green Supermix (BioRad), 2 mL of tem-
plate, and 300 pmol of each primer, and each sample was
analyzed in triplicate in an iQ5 thermal cycler (BioRad)
after 40 cycles. The cycle threshold (Ct) was determined,
and gene expression levels relative to that of GAPDH
were calculated by the 2–DDCt method, using the Gene
Study module of the iQ5 software (BioRad).
Slot Blot
Expression of key markers involved in extracellular matrix
remodeling and homeostasis was tested by slot blot. The
COL-I andMMP-1 protein levels secreted in cell supernatants
by BMSCs and tendon stem cells were assessed by slot blot.
For this purpose, cell culture media were concentrated 20-
fold with Centricon 10 columns (Amicon Y10; Millipore, Bill-
erica, Massachusetts). Protein content was determined by
a standardized colorimetric assay (DC Protein Assay; Bio-
Rad); 100 mg of total protein per sample in a final volume of
200 mL Tris-buffered saline (TBS) was spotted onto a nitrocel-
lulose membrane in a Bio-Dot SF apparatus (BioRad). Mem-
branes were blocked for 1 hour with 5% skimmed milk in
TBS containing 0.05% Tween 20 (TBST), pH 8, and incubated
for 1 hour at room temperature in a monoclonal antibody to
COL-I (1:1000 in TBST; Sigma-Aldrich) or to MMP-1 (1 mg/
mL in TBST; Millipore). After washing, membranes were
incubated in horseradish peroxidase (HRP)–conjugated rabbit
antimouse serum (1:40,000 in TBST; Sigma-Aldrich) for 1
hour. Immunoreactive bands revealed by the Amplified
Opti-4CN substrate (BioRad) were scanned densitometrically
(UVBand, Eppendorf, Hamburg, Germany).
Western Blot
Expression of key proteins involved in extracellular matrix
remodeling and homeostasis was tested by Western blot.
This technique allowed us to also distinguish the active
from the inactive protein forms.
ProMMP-1 and active MMP-1 protein levels were
assessed by Western blot. Concentrated culture media
(25 mg of total proteins) were diluted in a sodium dodecyl
sulfate (SDS) sample buffer, loaded on 10% SDS–polyacryl-
amide gel, separated under reducing and denaturing
conditions at 80 V, and transferred at 90 V to a nitrocellu-
lose membrane in 0.025 M Tris, 192 mM glycine, and 20%
methanol, pH 8.3. After electroblotting, the membranes
were air dried and blocked for 1 hour. After being washed
in TBST, membranes were incubated for 1 hour at room
temperature in monoclonal antibody to MMP-1 (1 mg/mL
in TBST; Millipore) and, after washing, in HRP-conjugated
rabbit antimouse serum (1:40,000 dilution; Sigma-
Aldrich). Immunoreactive bands were revealed using the
Amplified Opti-4CN substrate.
SDS-Zymography
This technique also allows testing the activity of key pro-
teins of the extracellular matrix. Concentrated culture
media were mixed 3:1 with sample buffer (containing
10% SDS). Samples (7 mg of total protein per sample)
were run under nonreducing conditions without heat dena-
turation onto 10% polyacrylamide gel (SDS-PAGE; Bio-
Rad) copolymerized with 1 mg/mL of type I gelatin. The
gels were run at 4C. After SDS-PAGE, the gels were
washed twice in 2.5% Triton X-100 for 30 minutes each
and incubated overnight in a substrate buffer at 37C
(50 mM Tris-HCl, 5 mM CaCl2, 0.02% NaN3, pH 7.5).
The MMP gelatinolytic activity was detected after staining
the gels with Coomassie brilliant blue R250, as clear bands
on a blue background.
Radiolabeling of Gangliosides and Neutral
Glycolipids by [3-3H]sphingosine and Analysis
To study the sphingolipid pattern of isolated cells, we per-
formed metabolic labeling with the radiolabeled precursor
[3-3H]sphingosine. Feeding cells with the precursor
allowed cells to synthesize radiolabeled sphingolipids
that could be easily analyzed and quantified as described
below.
Metabolic labeling of cell sphingolipids was achieved
with [3-3H]sphingosine (PerkinElmer, Waltham, Massa-
chusetts), as previously described,1 with a final concentra-
tion of 3 3 1028 M (corresponding to 0.4 mCi/well). Cells
(23 105 cells per 100-mm dish) were incubated in the pres-
ence of [3-3H]sphingosine for a 2-hour pulse followed by
a 48-hour chase, a condition warranting a steady-state
metabolic condition. At the end of the chase, cells were
washed and harvested in ice-cold PBS by scraping. The
cell suspensions were frozen and lyophilized. Total lipids
from lyophilized cells were extracted twice with 20:10:1
vol/vol (v/v) chloroform/methanol/water. Lipid extracts,
dried under a nitrogen stream, were dissolved in 2:1 (v/v)
chloroform/methanol and subjected to a 2-phase partition-
ing with 20% (v/v) water. The aqueous and organic phases
obtained were counted for radioactivity, and the contained
[3H]sphingolipids were analyzed by high-performance
thin-layer chromatography (Kieselgel 60, 20 3 10 cm;
Merck GmbH, Darmstadt, Germany), the solvent system
55:20:3 (v/v) chloroform/methanol/water and 60:40:9 (v/v)
chloroform/methanol/aqueous CaCl2 (0.2%) for the organic
and aqueous phases, respectively. Radioactive lipids were
visualized with a Beta-Imager 2000 (Biospace Lab, Paris,
France) and identified by comparison with radiolabeled
standards. The radioactivity associated with individual lip-
ids was determined with the specific b-Vision software
(Biospace Lab).
Osteogenic Differentiation
Cells were plated at the concentration of 3 3 104 cells/cm2
and treated with the osteogenic medium (10 nM dexameth-
asone, 10 mM glycerol-2-phosphate, 150 mM L-ascorbic
acid-2-phosphate, and 10 nM cholecalciferol, all purchased
from Sigma-Aldrich), the medium being changed 3 times
a week for 2 weeks. Osteogenic differentiation was
assessed by alkaline phosphatase (ALP) staining (Sigma-
Aldrich) according to the manufacturer’s procedures. The
Vol. XX, No. X, XXXX HRC and HLHB Stem Cells 5
ALP activity was determined using the Alkaline Phospha-
tase Detection Kit (Millipore) according to the manufac-
turer’s procedures, and ALP expression was determined
by qPCR (ALP: FW-CGCACGGAACTCCTGACC, REV-
GCCACCACCACCATCTCG). Total RNA was isolated
with the RNeasy Mini kit (Qiagen, Venlo, the Nether-
lands). The cDNA was synthesized starting from 0.8 mg
of RNA, with the iScript cDNA Synthesis Kit (BioRad)
according to the manufacturer’s instructions. Briefly,
10 ng of total RNA was used as a template for qPCR per-
formed using the iCycler thermal cycler (BioRad). The
PCR mixture included 0.2 mM gene-specific primers for
human ALP or human YWHAZ (14-3-3 protein zeta/delta),
which was used as housekeeper gene, and 50 mM KCl,
20 mM Tris/HCl (pH 8.4), 0.8 mM dNTPs, 0.7 U iTaq
DNA Polymerase, 3 mM MgCl2, and SYBR Green (iQ
SYBR Green Supermix; BioRad) in a final volume of
20 mL. Amplification and data acquisition were performed
using the following cycle conditions: initial denaturation at
95C for 3 minutes, followed by 40 cycles of 10 seconds at
95C and 30 seconds at 57C.
Adipogenic Differentiation
Cells were plated at a concentration of 3 3 104 cells/cm2 and
treated with the Mesenchymal Adipogenisis Kit (Chemicon,
Temecula, California), the medium being changed 3 times
a week for 3 weeks. Adipogenic differentiation was assessed
by evaluating AdipoRed staining (Chemicon) according to
the manufacturer’s procedures. Adipogenic marker expres-
sion was determined by qPCR (lipoprotein lipase [LPL]:
FW-AGAGAGAACCAGACTCCAATG, REV-GGCTCCAAG
GCTGTATCC; peroxisome proliferator-activated receptor–g
[PPAR-g]: FW-TTCCTTCACTGATACACTGTCTGC, REV-
GGAGTGGGAGTGGTCTTCCATTAC), following the same
procedure used for osteogenesis.
Skeletal Muscle Cell Differentiation and
Evaluation of Differentiation Markers
Cells were plated at the concentration of 23 103 cell/cm2 in
their cell culture medium. After 2 days, cells were washed
twice with PBS and twice with DMEM containing 10%
FBS. C2C12 myoblasts were then added to stem cells con-
taining plates in a ratio of 5:1. The following day, cocul-
tures were shifted in DMEM supplemented with 2%
horse serum. Differentiation was carried out for 7 days.
Cells were then fixed with 4% wt/vol (w/v) paraformalde-
hyde at room temperature for 10 minutes and then per-
meabilized with 0.1% (w/v) Triton X-100 and 1% (w/v)
BSA in PBS for 30 minutes. Cells were incubated for
2 hours at room temperature with the following primary
antibodies: antihuman nuclei antibody (Millipore) at
1:400 dilution and anti–myosin heavy chain (MHC) mono-
clonal antibody (Sigma-Aldrich) at 1:100 dilution. After
incubation, cells were washed 3 times in PBS and incu-
bated with the appropriate FITC- or TRIC-conjugated sec-
ondary antibodies 1 hour at room temperature. After being
washed in PBS, cells were analyzed under a fluorescent
microscope. Cell nuclei were counterstained with Hoechst
33342 (1:500) for 15 minutes.
RESULTS
Isolation and Characterization of Tendon Stem Cells
Isolation of SS and LHB stem cells was performed accord-
ing to the protocol described in the Materials and Methods
section and summarized in Figure 1E. Phase-contrast
microscopy of plated cells revealed that SS and LHB pos-
sessed similar morphologic characteristics, which were
also similar to those of BMSCs and DFs (Figure 1F). To
test whether cell populations were clonogenic, a typical
stem cell feature,3 2000-cell suspensions were plated in
60-mm dishes and cultured for 9 days. Cell colonies were
visualized using crystal violet staining, revealing that
SSs, LHBs, and BMSCs formed adherent colonies, whereas
DFs did not form significant colonies, as expected (Figure
1, G and H). Quantitative analysis of clonogenicity, per-
formed by counting the number of colonies per 100-mm
dish, revealed similar values for SSs, LHBs, and BMSCs
(Figure 1H). Cell growth was analyzed by counting plated
cells every 24 hours for 3 days and showed that SSs, LHBs,
and BMSCs possess comparable proliferation rates, which
were significantly lower than those for DFs, as expected
(Figure 1I). Cell cycle analysis by flow cytometry revealed,
in all cases, a cell cycle phase distribution (G1-S-G2/M)
typical of proliferating cell cultures (Figure 1J).
Tendon Stem Cell Phenotypization
Flow Cytometry Analysis. The LHB and SS cells were
phenotypically characterized by flow cytometry (see Sup-
plementary Figure S1, A and B and Figure S2, available
online at http://ajs.sagepub.com/supplemental/). The data
reported are the average values of all samples studied. In
particular, the SS values are the average of all 20 patients,
whereas those for LHB are the average of 6 patients. Sup-
plementary Figure S1A shows a representative analysis of
each marker, where the graph for each surface marker was
chosen so that it better represented the average results
obtained from all analyzed samples, which are reported
in Supplementary Figure S1B. Results revealed that both
cell populations were lineage (CD2, CD3, CD11b, CD14,
CD15, CD16, CD19, CD56, CD123, and CD235a) negative
and also negative for the hematopoietic markers (CD18,
CD34, and CD117) and the leukocyte marker CD45, con-
firming lack of contamination from these cell types. Both
LHB and SS cell populations were positive for the BMSC
markers CD90, CD44, CD146 but negative for CD18,
which was also negative in BMSCs, according to what
has been observed for human hamstring-tendon stem
cells.3 Stro-1 (a mesenchymal stem cell marker quite con-
troversial since the antigen recognized by the antibody is
still unknown and because of the variability of its expres-
sion reported in the literature)17 was negative in BMSCs
and DFs but was expressed by 7% of LHB and 13% of SS
stem cells. Vascular cell adhesion molecule 1 (VCAM-1 or
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CD106), a cell surface sialoglycoprotein that is downregu-
lated during BMSC differentiation,18 was expressed by
70% of BMSCs, 13% of LHB stem cells, and 16% of SS
stem cells. Analysis of CD106 mRNA levels, performed on
all isolated samples by qPCR, confirmed the distribution
observed by cytofluorimetry (see Supplementary Figure
S1C). The activated leukocyte cell adhesion molecule
(ALCAM, CD166), another putative mesenchymal stem
cell marker,20 could be detected by cytofluorimetry in
BMSCs and LHB and SS stem cells, as well as in DF cells
(Supplementary Figures S1B and S2).
Expression of Genes and Proteins Involved in Extra-
cellular Matrix Remodeling and Homeostasis. Gene expres-
sion analysis for COL-I, the main component of tendon
extracellular matrix (ECM), revealed increased mRNA levels
in SS and LHB tendon stem cells as compared with DFs and
BMSCs, and a similar pattern was observed in the gene
expression analysis for COL-III (Figure 2A). MMP-1 gene
expression was strongly downregulated in BMSCs and SS
and LHB stem cells compared with human dermal fibro-
blasts. By contrast, an opposite pattern was observed for
MMP-2, which was significantly upregulated in SS and
LHB stem cells and TGF-b1 (Figure 2A).
Genes for cell junction proteins showed a different pat-
tern of expression. N-cad mRNA levels were significantly
downregulated in BMSCs and SS and LHB stem cells. Con-
versely, Cx43 gene expression was higher in BMSCs and
SS and LHB stem cells (Figure 2F).
COL-I protein levels in cell supernatants were analyzed
by slot blot. Densitometric scanning of immunoreactive
bands revealed a very similar COL-I protein expression
in all the considered cell types (Figure 2B).
MMP-1 protein levels were analyzed by both slot and
Western blot using an antibody that can recognize both
pro- (inactive) and active MMP-1 (Figure 2, C and D).
The total MMP-1 protein levels were similar in DFs and
all stem cell supernatants; in particular, similar levels of
proMMP-1 and active MMP-1 were detected. MMP-2 activ-
ity analyzed by SDS-zymography resulted in similar DF
and stem cell supernatants (Figure 2E).
Sphingolipid Pattern Analysis. The sphingolipid profiles
in the organic and aqueous phases in the examined cells,
after metabolic radiolabeling with [3-3H]sphingosine, are
reported in Supplementary Figure S3 (available online).
With regard to the sphingolipid patterns in the organic
phase (Supplementary Figure S3, A and B), no significant
differences within the different cell populations were
observed for sphingomyelin (SM), ceramide (Cer), glucosyl-
ceramide (Glc-Cer), and lactosyl-ceramide (LacCer).
Instead, and notably, the relative content of a-galactosyl-
lactosylceramide (Gb3) in SS and LHB cells almost doubled
that in DFs and BMSCs. On the other hand, the sphingoli-
pid pattern in the aqueous phase (gangliosides) showed
remarkable differences within different cell types: GD1a
expression in the SS and LHB cells and BMSCs was much
lower (5- to 10-fold) than in the DFs, GM1 expression was
higher (about 3-fold) in SS than in DF cells, GM2 expression
was higher in DF than in the different stem cells, GM3
expression was higher (25%-30%) in BMSCs than in the
other cells, and GD3 expression was markedly higher (until
over 10-fold) in BMSCs and SS and LHB cells, as compared
with DFs, particularly in stem cells from human tendons.
Multipotency Analysis
Multipotency of SS and LHB cells was tested by inducing
cell differentiation of these cells toward osteoblasts, adipo-
cytes, and skeletal muscle. DFs and BMSCs were subjected
to the same differentiation experiments and were used as
controls for comparison with SS and LHB.
Osteogenesis was induced by culturing cells in the
appropriate differentiation medium for 3 weeks and
detected with alkaline phosphatase activity staining (Fig-
ure 3A), as described in the Materials and Methods. Alka-
line phosphatase expression was determined by qPCR and
revealed a 3- to 4-fold increase for BMSCs and SS cells and
a 6-fold increase for LHB cells as compared with DFs (Fig-
ure 3B). Alkaline phosphatase activity showed a 2.7-, 2.2-,
and 4.8-fold increase for BMSCs and SS and LHB cells, as
compared with DFs, respectively (Figure 3B).
Adipogenic differentiation was induced by culturing
cells in the appropriate differentiation medium (see Mate-
rials and Methods) for 3 weeks. Oil red staining revealed
the formation of mature adipocytes in all cultures with
the exception of DF (Figure 3C), as expected. Analysis of
adipocyte-specific markers PPAR-g and LPL by qPCR con-
firmed a significant expression increase of the genes in SS
and LHB cells, as compared with DFs, although signifi-
cantly lower than that observed in BMSCs (Figure 3D).
In particular, PPAR-g showed a 6.9-, 4.7-, and 3.1-fold
expression increase while LPL showed a 36.3-, 14.8-, and
12.7-fold increase for BMSCs and SS and LHB cells, as
compared with DF, respectively (Figure 3D).
To test whether tendon stem cells possess myogenic
competence to differentiate into skeletal muscle, cells
were cocultured with C2C12 murine myoblasts, in a 1:4
ratio. Skeletal muscle differentiation was induced as
described in the Materials and Methods. Coimmunostain-
ing with human nuclei (green) and MHC (red) antibodies
revealed the formation of myotubes incorporating human
nuclei (Figure 3E). Control experiments showed that no
human nuclei could be detected in myotubes formed by
coculturing DFs and C2C12 (Figure 3, E and F). On the
other hand, incorporation of human nuclei inside MHC-
positive myotubes could be observed with a frequency of
roughly 4% for BMSCs and 10% for both SSs and LHBs,
calculated by dividing the number of myotubes containing
at least 1 human nucleus by the overall number of myo-
tubes for each field (Figure 3, E and F).
DISCUSSION
In this work, 2 new adult stem cell populations from the SS
and LHB tendons were isolated, characterized, and cul-
tured in vitro. Cells showed adult stem cell characteristics
(ie, they were self-renewing in vitro, clonogenic, and multi-
potent), as they could be induced to differentiate into dif-
ferent cell types—namely, osteoblasts, adipocytes, and
skeletal muscle cells.
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Figure 2. (A) Bar graphs showing collagen type I (COL-I), collagen type III (COL-III), metalloproteinase 1 and 2 (MMP-1 and MMP-
2), and transforming growth factor–b1 (TGF-b1) mRNA levels in dermal fibroblasts (DFs), bone marrow stromal cells (BMSCs), and
supraspinatus (SS) and long head of the biceps (LHB) cells. Changes in mRNA are normalized to GAPDH gene expression. Values
are means 6 SD for triplicate samples. (B) Representative slot blot and bar graphs for COL-I protein levels in supernatants from
DFs, BMSCs, and SS and LHB cells. Data are means 6 SD for triplicate samples. (C) Representative slot blot and bar graphs for
MMP-1 protein levels in supernatants of DFs, BMSCs, and SS and LHB cells. Immunoreactive bands were obtained using a mono-
clonal antibody specific for both pro- and active MMP-1. Data are means 6 SD for triplicate samples. (D) Representative Western
blot for MMP-1 levels (the immunoreactive bands in the 60/50-kDa region correspond to proMMP-1 and active MMP-1) and bar
graphs showing proMMP-1 and MMP-1 protein levels. Data are expressed as densitometric units and are means 6 SD. (E) Rep-
resentative gelatin zymogram of MMP-2 in serum-free, conditioned supernatants from DFs, BMSCs, and SS and LHB cells. The
lytic bands in the 72-kDa region correspond to proMMP-2. Bar graphs show MMP-2 activity after densitometric analysis of lytic
bands following SDS-zymography. Data are expressed as densitometric units and are means 6 SD. Error bars show mean 6 SD
of 3 different experiments, with significance according to 2-way ANOVA: *P\ .05, **P\ .01, and ***P\ .001 compared with DF.
(F) Bar graphs showing N-cad and Cx43 mRNA levels in DFs, BMSCs, and SS and LHB cells. Changes in mRNA are normalized to
GAPDH gene expression. Values are means 6 SD for triplicate samples.
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Figure 3. In vitro differentiation of dermal fibroblasts (DFs), bone marrow stromal cells (BMSCs), and supraspinatus (SS) and long
head of the biceps (LHB) cells toward the osteogenic (A, B), adipogenic (C, D), and skeletal muscular cell phenotype (E, F). (A)
Alkaline phosphatase (ALP) staining revealed the presence of osteoblast-like cells (purple). A typical result is shown. (B) ALP
expression by quantitative polymerase chain reaction (qPCR) and ALP enzymatic activity. (C) Lipid vacuoles (red) in the adipo-
cytes were stained with Oil Red O solution. (D) Peroxisome proliferator-activated receptor–g (PPAR-g) and lipoprotein lipase
(LPL) expression by qPCR. (E) Skeletal muscle differentiation was induced by culturing cells in 2% horse serum medium for 7
days. Coimmunostaining with human nuclei (green) and myosin heavy chain (MHC, red) antibodies and staining of nuclei with
Hoechst 33342 (blue) revealed the formation of myotubes incorporating human nuclei (yellow) expressing sarcomeric myosin
in the cytoplasm only in BMSCs and SS and LHB cells. (F) Comparison of quantification of the incorporation of human nuclei
inside MHC-expressing myotubes was calculated by dividing the number of myotubes containing at least 1 human nucleus of
myotubes for each field. All quantitative data represent means 6 SD of 3 different experiments (significance according to 2-
way ANOVA: *P\ .05, **P\ .01, and ***P\ .001 compared with DFs). Hu, human.
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Rotator cuff tendon tears still suffer from the lack of
reliable alternative approaches to surgery and could
greatly benefit from the development of a stem cell–based
therapy. In general, tendon progenitor cells may represent
a new, endogenous, patient-specific stem cell source for tis-
sue regeneration. Like most other tissue-specific stem
cells, they are normally present in small numbers in adult
tissues and are in a quiescent state until properly stimu-
lated. With the present investigation, we report that
stem cells from the SS can be easily isolated, cultured,
and expanded in vitro. We name this family of stem cells
human rotator cuff stem cells (HRCSCs). Moreover, we
also isolated stem cells from the LHB, with a proliferation
and differentiation potential almost superimposable to
that of SS. We name this family of stem cells human
long head of the biceps stem cells (HLHBSCs). Thus, the
possibility of collecting LHB tendon fragments during rota-
tor cuff surgeries could be envisioned, particularly in those
patients in whom the LHB tendon is also damaged and is
normally discarded during surgery. This approach repre-
sents an alternative to the use of BMSCs, as tendon stem
cells could be collected in the same site of injury and at
the same time of tendon surgery, without requiring addi-
tional invasive procedures in other sites. Moreover, these
cells would be the same cells that are endogenously acti-
vated after injury and might be induced to differentiate
into tenocytes by the inflammatory response. Therefore,
they are expected to have a better regenerative potential
than other stem cell sources coming from other tissues.
This issue was also faced in our investigation with a com-
parative analysis of the differences at the molecular level
among SS and LHB stem cells, BMSCs, and DFs to reveal
common and different features. In particular, tissue-
specific and stem cell markers were analyzed by cyto-
fluorimetry, revealing that SS and LHB cells are very sim-
ilar to each other, but they differ from BMSCs in the
expression level of key stem cell markers such as CD106
and Stro-1. How these differences would affect the regener-
ative potential of these cells is a matter for further investi-
gation. In the search of further characterization of the 2
newly isolated tendon stem cell populations, the sphingoli-
pid patterns of all cell types used were determined and
compared. The levels of sphingomyelin, ceramide, glucosyl-
ceramide, and lactosylceramide were very similar in all the
different cells, whereas Gb3 was markedly more abundant
in SS and LHB tendon stem cells as compared with BMSCs
and DFs, which exhibited very similar contents. This find-
ing, potentially interesting, requires further investigation.
The ganglioside pattern also showed remarkable differen-
ces: GD1a level was markedly lower in all stem cells,
including SS and LHB stem cells, as compared with prolif-
erating human fibroblasts, whereas GD3 was much more
abundant in all stem cells, particularly in LHB cells, as
compared with DFs. These novel findings, which deserve
more detailed investigations, further corroborate the
notion that glycosphingolipids, particularly gangliosides,
present on the plasma membrane and often enriched in
the lipid rafts, are involved in the regulation of key recep-
tors implicated in cell differentiation and prolifera-
tion.15,16,35 These results are also in accordance with
other studies reporting the involvement of GD1a in stem
cell differentiation, where its increase was necessary for
the progression of the process.36 Overall, increasing evi-
dence seems to support the hypothesis that GD1a levels
could be a direct expression of the differentiation stage of
a stem cell.
The newly isolated tendon stem cells were also analyzed
for their phenotype in relation to their activity in ECM
remodeling, since ECM plays a key role in maintaining
tendon structure and biomechanical properties. COL-I is
the main component of the dense connective tissue of ten-
dons, accounting for 60% to 80% of the dry mass.11 COL-I
and COL-III mRNA levels were both upregulated in SS
and LHB stem cells, compared with DFs and BMSCs,
according to TGF-b1 gene expression.8 It is interesting to
note significant differences in COL-I and COL-III expres-
sion between SS and LHB. As many factors could influence
COL-I and COL-III expression in vitro, including the
choice of the culturing medium, understanding the reasons
for the observed differential expression will require further
investigation. Also, a therapeutic potential was recently
suggested for PRGFs,7 containing many growth factors act-
ing on ECM turnover to enhance the repair of supraspina-
tus tendon enthesis. Although TGF-b1 is the main growth
factor inducing fibroblast proliferation and ECM compo-
nents synthesis, we cannot speculate on the possible local
delivery of TGF-b1 to induce tendon healing for 2 main
reasons. First, the intermediate portion of tendons has
a structure completely different from the structure of
enthesis. Second, the uncontrolled and persistent activity
of TGF-b1 could be responsible for the unbalanced deposi-
tion of collagen and ECM components in tendons. COL-I
and COL-III induction was described as a regenerative
and healing response in injured tendons.21 Our data show-
ing COL-I and COL-III mRNA level upregulation in SS
and LHB tendon stem cells seem to suggest for these cells
a greater ability for tendon healing compared with BMSCs.
However, this hypothesis was not confirmed by the analy-
sis of COL-I protein levels, the main collagen type in ten-
dons, since the expression of COL-I at the protein level
was similar in all the considered cell types. The inconsis-
tency of COL-I mRNA and protein levels in BMSCs and
LHB and SS stem cells and the finding of unmodified
COL-I protein levels in all cell supernatants suggests a dif-
ferent posttranscription and/or posttransduction regula-
tion of the COL-I gene in tendon stem cells. Collagen
content is dependent on the finely regulated dynamic bal-
ance between its synthesis and degradation by MMPs.
MMP-1 is necessary to begin the collagen degradation
pathway since it can cleave the native triple helical region
of interstitial collagens into characteristic 3/4- and 1/4-
collagen degradation fragments, also known as gelatins,28
that can be further degraded by less specific proteinases
such as MMP-2, leading to complete digestion of the fibril-
lary collagen.34 MMP-1 and MMP-2 protein levels and
activity were similar in all the considered cell superna-
tants, as observed for COL-I protein expression. These
findings suggest that SS and LHB cells are characterized
by increased COL-I mRNA levels compared with DF and
BMSC cells but have similar COL-I, MMP-1, and MMP-2
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protein expression. We can therefore hypothesize a differ-
ent regulation for the COL-I gene, possibly occurring at
a posttranscription or maturation level. Moreover, as teno-
cytes are arranged in longitudinal rows between the fiber
bundles in mature tendons, they are intimately connected
cell to cell with neighboring cells, both with the same cell
row and with parallel rows, containing adherens and gap
junctions formed by Cx32 and Cx43.22 Therefore, N-cad
is the transmembrane protein of adherens junctions in
mesenchymal cells, supported by the actin cytoskeleton,
that contributes to cell-cell interaction and to mechano-
transduction mechanisms in response to mechanical
load.14 Analysis of N-cad mRNA levels revealed a higher
expression in DFs, which is consistent with an increased
cell-cell adhesion or cell-matrix adhesion, as compared
with both BMSCs and tendon stem cells. This suggests
that adult fibroblasts are involved in maintaining the
integrity of the longitudinal tendon rows and monitoring
tensile load more than stem cells and that BMSCs and ten-
don stem cells display a similar phenotype in relation to
N-cad expression.
Cx43 allows cell communication both longitudinally and
laterally, contributing to the maintenance of tendon ECM
homeostasis in response to tendon mechanical loading,
allowing coordination of synthetic activity and facilitating
strain-induced collagen synthesis. Our results show an
increased Cx43 gene expression in BMSCs and SS and
LHB tendon stem cells compared with DF. According to
a previous study, which showed Cx43 mRNA upregulation
in immature tendons,30 we can hypothesize that tendon
stem cells are immature cells having a high Cx43 expres-
sion to provide a sustained gap-junction communication
that is necessary for the differentiation process.
Overall, our results confirmed that both SSs and LHBs
could be efficiently induced to differentiate into osteo-
blasts, adipocytes, and even skeletal muscle cells, where
bone marrow stem cells gave poor results. Further studies
to test the differentiation potential of SS and LHB stem
cells in vivo are now necessary to understand their full
potential in regenerative medicine.
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